Back
Accuray Vs. Perspective Therapeutics Industry Stock Comparison
Sell
35
ARAY
Accuray
Last Price:
1.94
Seasonality Move:
12.39%
Sell
30
CATX
Perspective Therapeutics
Last Price:
12.47
Seasonality Move:
26.28%
Sell
35
Accuray (ARAY)
is a Sell
Is Accuray a Buy, Sell or Hold?
- The current Accuray [ARAY] share price is $1.92. The Score for ARAY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ARAY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $12.34. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $12.34
The current trend is relatively stagnant and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARAY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 55.87 | Buy |
| Chaikin Money Flow: | 641177 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.76 - 1.88) | Buy |
| Bollinger Bands (100): | (1.66 - 2.08) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 48.71 | Sell |
| Chaikin Money Flow: | 329079 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.9 - 13.06) | Sell |
| Bollinger Bands (100): | (11.22 - 14.34) | Sell |
ARAY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.82 | Buy |
| 20-day SMA: | 1.82 | Buy |
| 50-day SMA: | 1.9 | Buy |
| 200-day SMA: | 2.07 | Sell |
| 8-day EMA: | 1.82 | Buy |
| 20-day EMA: | 1.82 | Buy |
| 50-day EMA: | 1.86 | Buy |
| 200-day EMA: | 2.08 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.9 | Buy |
| 20-day SMA: | 12.33 | Buy |
| 50-day SMA: | 13.38 | Sell |
| 200-day SMA: | 12.62 | Sell |
| 8-day EMA: | 12.07 | Buy |
| 20-day EMA: | 12.31 | Buy |
| 50-day EMA: | 12.82 | Sell |
| 200-day EMA: | 11.77 | Buy |
Accuray Earnings Growth & ARAY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $0.14 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.
Accuray Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||